RecruitingNCT06182657

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jiangxi Provincial Cancer Hospital
Principal Investigator
Jingao Li, PhD
Jiangxi Provincial Cancer Hospital
Enrollment
300 target
Eligibility
18 years · All sexes
Timeline
20242029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06182657 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma

← Back to all trials